期刊文献+

多巴胺与去甲肾上腺素治疗感染性休克的效果对比 被引量:1

下载PDF
导出
摘要 目的:对比分析用多巴胺注射液与去甲肾上腺素注射液治疗感染性休克的效果。方法:将我院收治的110例感染性休克患者分为治疗组(n=56例)与常规组(n=54例),对两组患者进行常规治疗,在此基础上为常规组患者应用多巴胺注射液进行治疗,为治疗组患者应用去甲肾上腺素注射液进行治疗,然后对比分析其临床疗效。结果:与常规组患者相比,治疗组患者治疗的总有效率较高,差异有统计学意义(P<0.05)。结论:与采用多巴胺注射液相比,应用去甲肾上腺素注射液治疗感染性休克可取得更为理想的临床效果,此法值得在临床上推广应用。 objective: to summarize the dopamine and norepinephrine in the application of shock treatment effect. Methods:selection from jan 2015 to jan 2016 treated in our hospital, a total of 110 patients with shock, it is divided into two groups: treatment group (n=56 cases, administered to the thyroid gland), and normal group (n=54 cases with dopamine), the two groups in the application of shock treatment effect were compared. Results: after treatment, the treatment group total effective rate, 1 h, 6 h after treatment the blood lactate clearance rate is significantly higher than normal group (P〈0.05). Conclusion: in treatment of patients with shock, imposing dopamine and thyroxine, help to improve the clinical curative effect, and the application effects of norepinephrine is superior to dopamine, has high clinical value.
作者 邓容
出处 《当代医药论丛》 2017年第2期119-120,共2页
关键词 多巴胺注射液 去甲肾上腺素注射液 休克 临床疗效 dopamine Thyroid hormone Shock Clinical curative effect
  • 相关文献

参考文献3

二级参考文献27

  • 1徐裕海,李桂新,刘谦慧.感染性休克体液复苏治疗后C反应蛋白和降钙素原动态变化的研究[J].大连医科大学学报,2009,31(1):95-97. 被引量:30
  • 2邵将,贾连顺,朱巍,陈雄生,袁文.颈髓损伤早期死亡影响因素与时间分布[J].中华骨科杂志,2007,27(8):561-565. 被引量:40
  • 3Ohira H, Nomura M, lchikawa N, et al. Association of neural and physiological responses during voluntary emotion suppression[J] Neurolmage, 2006,29 (3) : 721-733.
  • 4Bar M, Kassam K S, Ghuman A S, et al. Top-down facilitation of visual recognition [J]. Proc Natl Acad Sci U S A, 2006, 103 (2) : 449-454.
  • 5Wahher D J, Bader M. A unique central tryptophan hydroxylase isotbrm[J]. Bioehem Pharmacol, 2003,66 (9) : 1673-1680.
  • 6Sabol S Z, Hu S, Hamer D. A function polymorphism in the monoamine oxidase A gene promoter [J]. Hum Genet, 1998, 103(3) :273-279.
  • 7Monakhov M, Golimbet V, Abramova L, et al. Associationstudy of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population [J]. Schizophr Res, 2008,100(1-3) : 302-307.
  • 8He M, Yah H, I)uan Z X, et al. Genetic distribution and association analysis of DRD2 genc polymorphisms with major depressive disorder in the Chinese Han population [J]. lnt J Clin Exp Pathol, 2013,6(6):1142-1149.
  • 9Hayden E P, Klein D N, Dougherty L R, et al. The dopamine D2 receptor gene and depressive and anxious symptoms in childhood: associations and evidence for gene-environment correlation and geneenvironment interaction [Jl. Psychiatr Genet, 2010,20(6) : 304-310.
  • 10Huuhka K, Anttila S, Huuhka M, et al. Dopamine 2 receptor C957T and catechol -o-methyltransferase Val158Met polymorphisms are associated with treatment response in eletroconvulsive therapy [J]. Nenrosci Lett, 2008,448 (1) : 79-83.

共引文献21

同被引文献11

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部